| Heading: |
Rare Cancers: Surrey Heath |
| Question ID: |
1787368 |
| UIN: |
40366 |
| House: |
Commons |
| Date tabled: |
2025-03-21 |
| Asking Member ID: |
5288 |
| Asking Member display name: |
Dr Al Pinkerton
|
| Asking Member handle: |
|
| Asking Member Twitter reference: |
Dr Al Pinkerton
|
| Member interest: |
false |
| Question text: |
To ask the Secretary of State for Health and Social Care, what assessment has he made of the potential merits of increasing research funding for rare cancers in Surrey Heath constituency. |
| Is named day: |
false |
| Date of holding answer: |
|
| Date answered: |
2025-03-28 |
| Date answer corrected: |
|
| Is holding answer: |
false |
| Is correcting answer: |
false |
| Answering Member ID: |
4981 |
| Answering Member display name: |
Ashley Dalton
|
| Answering Member handle: |
AshleyDalton_MP
|
| Answering Member Twitter reference: |
@AshleyDalton_MP
|
| Correcting Member ID: |
|
| Correcting Member display name: |
|
| Correcting Member handle: |
|
| Correcting Member Twitter reference: |
|
| Answer text: |
Research is crucial in tackling cancer, which is why the Department, through the National Institute for Health and Care Research (NIHR), invests over £1.6 billion per year in health research. In 2023/24, the NIHR invested £133 million in cancer research. ... |
| Original answer text: |
|
| Comparable answer text: |
|
| Answering body ID: |
17 |
| Answering body name: |
Department of Health and Social Care |
| Tweeted: |
true |